, Masafumi Seki 1) , Hiroshi Kakeya 1) , Yoshihiro Yamamoto 1) , Shimeru Kamihira 2) , and Shigeru Kohno
Second Department of Internal Medicine, 2) Department of Laboratory Medicine, and The mutant prevention concentration (MPC) concept has been suggested as a useful tool for guiding the appropriate use of antimicrobial drugs in order to decrease the selection of resistant bacteria 4 . Additionally, the mutant selection window (MSW) is an antimicrobial concentration range extending from the minimal concentration required to block the growth of wild-type bacteria up to that required to inhibit the growth of the single-step mutant, and the upper boundary is also called the MPC 1, 4 . Sitafloxacin is a new fluoroquinolone that has been reported to have a broader spectrum, and the greater activity against quinolone-resistant strains than that of other quinolones 5 . The purpose of this study was to evaluate the in vitro activity of sitafloxacin and compare its MPC and MSW to those of levofloxacin, moxifloxacin, garenoxacin, and ciprofloxacin. To identify mutations in the QRDRs of gyrA and parC in these strains, PCR and direct DNA sequencing were used according to the method of Vila et al 7 . The QRDR DNA sequencing results were compared with the sequence of strain Rd (GenBank accession no. NC_000907), which was used as the wild-type standard strain in this study. The MPC is defined as the fluoroquinolone concentration at which no colony was recovered when more 4 than 10 10 cells were applied to agar plates, and generally, it is also defined the lower limit of the MSW equal to the MIC 5 . The MPC methodology was adapted from the method outlined by Blondeau et al 1 . First, the bacterial isolates were grown up on chocolate II agar plates (10 plates per isolate) (Nissui Pharmaceutical Co., Tokyo, Japan) and incubated overnight at 37°C in 5% CO 2 . Then, colonies from each strain were transferred from the plates to 200 ml of Mueller Hinton II broth (Beckton Dickinson, Oxford, UK) containing 2% lysed horse blood and 15 µg / ml NAD and then incubated with vigorous shaking for 2 h at 37°C. Each 200 ml culture was then centrifuged at 5000 rpm for 30 min. The pellets of the same strain were combined to make the final suspension of ≥ 3 × 10 10 CFU / mL. For the MPC determination, 100 l of this concentrated bacterial suspension was used to inoculate each fluoroquinolone plates. These plates were incubated at 37°C in 5% CO 2 and were screened for colonies every 24 h over 96 to 120 h to ensure that the colony number had stabilized. Table 1 appears to the MPC and MIC ratios which will give the idea of the MSW size.
Results and Discussion
The MPC of sitafloxacin was the lowest of the five fluoroquinolones tested, and its MSW 
